Task: Answer the multiple choice question.
Query: Which drug exhibits a -10.162% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) Cc1ccc(-c2noc(C3CCCN(C(=O)c4cccc([N+](=O)[O-])c4)C3)n2)o1
b) O=C(N1CCOCC1)C12CC3CC(C1)CC(n1cnc(Cl)n1)(C3)C2
c) COc1ccc([C@H]2CC(=O)C=C(c3cc(C)ccc3OC)C2)cc1
d) Clc1cccc(/C=N/Nc2nc(Cl)nc3ccccc23)c1
e) COc1ccc2c(c1OC)C(=O)OC2CC(=O)c1ccc(O)c(O)c1
Answer: b. O=C(N1CCOCC1)C12CC3CC(C1)CC(n1cnc(Cl)n1)(C3)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(N1CCOCC1)C12CC3CC(C1)CC(n1cnc(Cl)n1)(C3)C2
O=C(N1CCOCC1)C12CC3CC(C1)CC(n1cnc(Cl)n1)(C3)C2
[3-(3-chloro-1,2,4-triazol-1-yl)-1-adamantyl]-morpholin-4-ylmethanone